Loading
People with serious mental illness or dementia are routinely excluded from cancer trials by vague compliance clauses, though they get cancer just as often and do worse. Replacing those clauses with assessable criteria, and funding supported consent and accommodations such as longer visits, would let them take part.
Protocols replace 'psychiatric illness that would interfere with compliance' and similar clauses with specific, assessable criteria; supported decision-making, legally authorised representative consent where appropriate, and accommodations (longer visits, carer involvement, simplified materials) are funded. Enrolment and outcomes for these groups are reported.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly, National Cancer Institute (NIH).
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, National Cancer Institute (NIH).
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly, National Cancer Institute (NIH).
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly, National Cancer Institute (NIH).
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, National Cancer Institute (NIH).
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly, National Cancer Institute (NIH).